FREE FULL TEXT (PDF) 

UDC 339.5:615.32		DOI: https://doi.org/10.31617/zt.knute.2019(106)07
SHKREBTIIENKO Anna, E-mail: Ця електронна адреса захищена від спам-ботів. вам потрібно увімкнути JavaScript, щоб побачити її. ORCID: 0000-0002-5310-9881		Postgraduate student, Department of International Public Law, Kyiv National University of Trade and Economics 19, Kyoto str., Kyiv, 02156, Ukraine

WORLD MARKET OF BIOLOGICAL MEDICINES 

The advantages and disadvantages of globalization in the medicines market are identified. It is proved that harmonization of standards, provision of the regulatory mechanism of state cooperation in the pharmaceutical sector helps to avoid significant differences in the requirements for registration of medicinal products, reduce duplication of national procedures for the registration of medicinal products, which may affect the access of medicinal products to the global market for biological drugs.
 
Keywords: globalization, drug market, competitiveness, biological medicinal product, trade, international cooperation, harmonization of standards. 

 REFERENCES 

1. Fidler, D. P., & Calamaras, J. L. (2010). The challenges of global health governance. Council on Foreign Relations Press. New York. May [in English].
2. Bilousov, Ye. M. (2012). World economic order and law in the conditions of globalization (problem statement). Processes of economic globalization and directions of modernization of legal economic order in Ukraine: materials of the round table (Kharkiv, April 26, 2012). VS Milas - Kh. Yurayt. P. 30-34 [in English].
3. Pashkov, V. M. (2014). The Globalization of the Pharmaceutical Market: Problems and Prospects. The Bulletin of the National University «Legal Academy of Ukraine named after Yaroslav the Wise», 1, 148-159 [in English].
4. Deshko, L. (2008). Do pytannja pro licenzuvannja gospodars’koi’ dijal’nosti v sferi ohorony zdorov’ja [To the question of licensing of economic activity in the field of health care]. medicallaw.org.ua. Retrieved from http://medicallaw.org.ua/uploads/media/02_091_01.pdf [in Ukrainian].
5. Mironishina, O. V. (2007). The Globalization of the Pharmaceutical Industry: Impact of Impact on the Ukrainian Economy. Vysn. Donets un-t, 2, 153-168 [in English].
6. Makarenko, A. (2006). The ABC and the arithmetic of the WTO. Weekly Pharmacy, 38 (559), 10-13 [in English].
7. Deshko, L. (2018). Patenting of medicinal products: the experience of implementation of the flexible provisions of the TRIPS-plus Agreement by foreign countries and the fundamental patent reform in Ukraine. Georgian Medical News, 9, 161-164 [in English].
8. Ukraine and the WTO. (2006). Patent Law and Medicines / Weekly Pharmacy, 50 (321), 19-23 [in English].
9. State Expert Center of the Ministry of Health of Ukraine. Retrieved from http://www.dec.gov.ua/index.php/ua/2-uncategorised/ 1971-dets-rozpochav-vprovadzhennya-kerivnikh-polozhen-vooz-po-biotekhnologichnim-preparatam-u-tomu-chisli-biopodibnim [in English].